logo-loader
CSE:AGN OTCQB:BTHCF

Algernon Pharmaceuticals Inc.

Receive alerts
Market:
CSE
Market Cap:
$19.01 m
Price
0.27 CAD
Change
12.77%
52 weeks high
0.35
52 weeks low
0.04

In brief

Algernon Pharmaceuticals is a clinical stage pharmaceutical development company focused on the areas of non–alcoholic steatohepatitis (NASH), chronic kidney disease (CKD) and inflammatory bowel disease (IBD). Algernon’s key compounds were identified using a drug repurposing strategy.